CO-TECHSTARS
20.4.2022 14:02:25 CEST | Business Wire | Press release
Techstars, a global investment business that provides access to capital, one-on-one mentorship, and customized programming for early-stage entrepreneurs, announces two strategic and operational leaders who will join the global management team effective immediately. Aparna Ramaswamy will serve as the new Chief Human Capital Officer and Kimberly Smith has been appointed to the newly formed role as Chief Capital Formation Officer, both positions report to CEO, Maëlle Gavet.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220420005309/en/
“The best capital - whether human or financial - will pave the way for Techstars in its ambition to become the largest pre-seed investor," said Gavet. "These two deeply talented and experienced operational leaders will help Techstars continue its growth worldwide for our proven and scalable investment business."
As the new Chief Human Capital Officer, Ramaswamy has experience across a diverse portfolio of global businesses and industries/sectors including financial services, oil and gas, security, aviation, and public education. She has a recognized track record of shaping change through a strategic approach of aligning people and culture to enable businesses to scale and solve complex problems. In her most recent role as Chief Human Capital Officer for Success Academy Charter Schools in New York City, she introduced an innovative two-year leadership fellows program (Robertson Leadership Fellows) to accelerate and build the school leadership pipeline at scale and also created and led the first Inclusion Council and DEI commitments for a network of 47 public charter schools serving 20,000 children across four NYC boroughs. With Techstars’ recent announcement , launching nine diverse-led accelerators programs in partnership with J.P. Morgan, Ramaswamy’s experience in building and leading DE&I related initiatives at scale will be invaluable to the organization.
Prior to her most recent leadership role with Success Academy Charter Schools, Ramaswamy served as Co-Head of Human Resources at Bridgewater Associates and before that, spent 14 years at General Electric (GE) in progressively larger global Human Resources leadership roles across multiple businesses and industries. Based in Stamford, Connecticut, she plans to bring to Techstars her broad and varied range of global experience in talent acquisition, leadership capacity building, talent management, and total rewards, to reinforce operational excellence and deliver on Techstars’ key strategic objectives.
Ramaswamy received a Bachelor of Arts in Sociology and Psychology from St. Xavier’s College in Mumbai, India, a Master of Arts in Sociology from the University of Mumbai, India, and a Master of Business Administration from the University of Michigan Ross School of Business. In her free time, she serves on the American India Foundation Tri-State Board and is a member of the Vitalize VC Angels investment community, and the Chief Network.
Named as Techstars’ first Chief Capital Formation Officer, Smith joined the company in September 2021 and immediately began making an impact through her influence with prospective and existing investors and Limited Partners (LPs). She was integral in helping the organization close the Advancing Cities fund last month.
Based in New York City, she will be responsible for Tecshstars’ fundraising and investor relations while cultivating relationships with current and future investors - both traditional institutional LPs as well as individuals and strategic investors. Smith has spent her career raising money in the investment management sector and before joining Techstars, spent 15+ years with Owl Creek Asset Management, a NY-based event driven hedge fund, where she was a Partner and responsible for raising and retaining billions of investor capital. She has also held leadership positions in Investor Relations and Marketing at Davidson Kempner, traded coffee and sugar in the Global Futures group at ABN AMRO and got her start in finance working at Ziff Brothers.
Smith received her Bachelor of Arts from Middlebury College and her Masters of Business Administration from Fordham University. She is also the Chair of both the Board of Trustees and the Investment Committee at the Ethical Culture Fieldston School in New York City.
Following four other executive appointments within the last year, Techstars is taking bold and ambitious steps toward bringing together an industry team of leaders focused on building and growing a world-class investment business at scale.
About Techstars
The Techstars worldwide network helps entrepreneurs succeed. Founded in 2006, Techstars began with three simple ideas—entrepreneurs create a better future for everyone, collaboration drives innovation, and great ideas can come from anywhere. Now we are on a mission to enable every person on the planet to contribute to, and benefit from, the success of entrepreneurs. In addition to operating accelerator programs and venture capital funds, we do this by connecting startups, investors, corporations, and cities to help build thriving startup communities. Techstars has invested in more than 3,000 companies with a combined market cap of more than $172B. www.techstars.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20220420005309/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First-in-Class B7H3/PTK7 Bispecific TOP1 ADC IDE03428.2.2026 01:00:00 CET | Press release
IDE034 is a B7H3/PTK7 bispecific TOP1 ADC designed to target tumor cells expressing both B7H3 and PTK7 preferentially, and is being evaluated as monotherapy and in combination with IDEAYA’s PARG inhibitor IDE161. IDEAYA has dosed the first patient in its Phase 1 trial of IDE034, initially evaluating safety, tolerability, and PK. First dosing triggers a $5 million milestone payment to Biocytogen under the companies’ option and license agreement. Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that its partner IDEAYA Biosciences, Inc. (“IDEAYA”; Nasdaq: IDYA) has dosed the first patient in IDEAYA’s Phase 1 dose-escalation/expansion clinical trial of IDE034, an investigational B7H3/PTK7 bispecific TOP1 ADC. Pursuant to the companies’ option and license agreement, first patient dosing triggers a $5 million
IQM and Real Asset Acquisition Corp. to Host Conference Call/Webcast to Discuss Proposed Transaction27.2.2026 13:00:00 CET | Press release
IQM Finland Oy, a global leader in full-stack superconducting quantum computers (“IQM”, “IQM Quantum Computers” or the “Company”), and Real Asset Acquisition Corp. (Nasdaq: RAAQ), a special purpose acquisition company (“RAAQ”), announced that they will host a conference call to discuss their recently announced business combination, including certain transaction highlights. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260227472716/en/ IQM Radiance quantum computer As previously disclosed, on February 23, 2026, IQM and RAAQ announced they have entered into a definitive business combination agreement, which will result in IQM becoming a public company and listing American Depositary Shares on one of the two leading U.S. stock exchanges. The transaction provides funding with the aim to accelerate IQM’s technology and commercial development towards fault-tolerance quantum computing, further advancing its position as a leading p
HighRadius Launches $0 Implementation Fee, $0 Subscription Fee via Outcome Based Pricing for oCFO Software27.2.2026 12:00:00 CET | Press release
HighRadius launches Office of the CFO first Outcome Based Pricing with $0 Implementation fee and $0 Subscription until Go-Live. Customers only pay a fraction of realized gains based on P&L impact. Chapter 1: Outcome Based Pricing (OBP)Introduction of OBP: HighRadius, a provider of 190+ AI agents for Order-to-Cash, Accounts Payable, Record-to-Report, and Treasury introduces Outcome Based Pricing (OBP). Three Components of OBP: Customers pay a) $0 in Implementation fees, b) $0 in Subscription fees until Go Live, c) HighRadius earns a fraction of the actual savings realized by the client. Chapter 2: US GAAP & ASC 606 ConstraintsNot Designed for Innovation: The traditional ASC 606 model requires companies to standardize and recognize revenue based on contractual obligations. For a traditional SaaS subscription, the obligation is access to software over time. AI agents are designed to deliver quantifiable, real-time Business Outcomes that do not fit the traditional accounting framework. Cha
Kioxia Appoints Yoshihiko Kawamura as Chief Financial Officer27.2.2026 09:15:00 CET | Press release
Kioxia Holdings Corporation (TOKYO:285A), a world leader in memory solutions, today announced the appointment of Yoshihiko Kawamura as Chief Financial Officer (CFO), effective April 1, 2026. Mr. Kawamura brings extensive international experience to Kioxia, having held assignments at Mitsubishi Corporation’s U.S. headquarters, served as General Manager of its Chicago office, and completed a tenure at the World Bank. At Hitachi, Ltd., he held senior leadership positions, including Chief Strategy Officer (CSO), Chief Financial Officer (CFO), and Chief Risk Management Officer (CRMO), where he was instrumental in leading the company’s management reforms. Since joining Kioxia as Executive Vice President in June 2025, Mr. Kawamura has worked closely with the executive team to advance the business through strategic capital and financial planning. Following its initial public offering on the Prime Market of the Tokyo Stock Exchange in December 2024, Kioxia is entering a new phase of growth char
DNP Invests in Rapidus to Support the Establishment of Mass Production for Next-Generation Semiconductors27.2.2026 08:18:00 CET | Press release
Will accelerate the development and mass production of EUV lithography photomasks Dai Nippon Printing Co., Ltd. (DNP, TOKYO:7912) today announced that it has participated in Rapidus Corporation’s funding round as one of the round investors. This strategic funding initiative supports Rapidus’ plan to steadily progress from its current R&D phase to mass production of 2nm (10⁻⁹ meters) logic semiconductors by 2027. Through this initiative, DNP will advance the development and mass production of EUV lithography photomasks and support Rapidus as it establishes a mass production system for 2nm & next-generation semiconductors. Background In recent years, the rise in energy consumption, in line with increased data generation, has become a challenge, driving demand for next-generation semiconductors capable of improving device performance and reducing power consumption. Next-generation semiconductors manufactured using EUV lithography enable the formation of finer patterns on silicon wafers co
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
